Candel Therapeutics, Inc. · NASDAQ:CADL
BlackRock, Inc. reported a 6.60% stake in Candel Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.60% stake in Candel Therapeutics, Inc., 4,834,899 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 6.60%
- Shares
- 4,834,899
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.60% | 4,834,899 |
Source
Related
- Candel Therapeutics, Inc.
- BlackRock, Inc.
- Candel Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Form 4 · Tyagarajan Seshu · Jul 1, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026